Search all bills

TOTAL RESULTS: 4139

• Therapeutic Goods and Other Legislation Amendment Bill 2002

  Track (What's this?)

  Date

  21 Mar 2002 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health and Ageing 

  Summary

  Amends the:

  Therapeutic Goods Act 1989

  to: clarify the powers, functions and duties of Commonwealth officials and authorities within the Commonwealth-State cooperative scheme for the regulation of therapeutic goods (as a consequence of the High Court’s decision in R v Hughes); enable the implementation of the mutual recognition agreement entered into between Australia and Singapore relating to the manufacture of medicines; provide for implementation of other similar mutual recognition agreements; enable collection of information and documents in relation to blood and blood component manufacturing processes and practices; clarify the timeframe for payment of evaluation fees; and allow the Minister to impose conditions for the listing of goods on the Australian Register of Therapeutic Goods;

  Industrial Chemicals (Notification and Assessment) Act 1989

  and

  National Occupational Health and Safety Commission Act 1985

  to reflect new administrative and financial arrangements required as a result of changed portfolio responsibilities; and proposed

  Therapeutic Goods Amendment (Medical Devices) Act 2002

  , if it commences after this proposed Act, in relation to the definition of “conformity assessment certificate”. 

  Bill | Explanatory Memorandum

• Therapeutic Goods Amendment Bill (No. 1) 2002

  Track (What's this?)

  Date

  20 Feb 2002 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health and Ageing 

  Summary

  Amends the

  Therapeutic Goods Act 1989

  to enable the Minister to allow the importation, manufacture or supply of unapproved therapeutic goods that are needed to treat large numbers of patients in a national emergency. Also provides for strengthened offence provisions and recording keeping and reporting requirements in relation to such unapproved therapeutic goods. 

  Bill | Explanatory Memorandum

• Therapeutic Goods (Charges) Amendment Bill 2002

  Track (What's this?)

  Date

  14 Feb 2002 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health and Ageing 

  Summary

  Introduced with the Therapeutic Goods Amendment (Medical Devices) Bill 2002, the bill amends the

  Therapeutic Goods (Charges) Act 1989

  to provide for annual charges to be payable for medical devices to be included on the Australian Register of Therapeutic Goods. 

  Bill | Explanatory Memorandum

• Therapeutic Goods Amendment (Medical Devices) Bill 2002

  Track (What's this?)

  Date

  14 Feb 2002 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health and Ageing 

  Summary

  Introduced with the Therapeutic Goods (Charges) Amendment Bill 2002, the bill amends the

  Therapeutic Goods Act 1989

  to introduce a medical device regulatory system, including a new electronic application lodgment system for inclusion of medical devices on the Australian Register of Therapeutic Goods; and provides transitional arrangements. 

  Bill | Explanatory Memorandum

• Medical Indemnity (Competitive Advantage Payment) Bill 2005

  Track (What's this?)

  Date

  16 Jun 2005 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health and Ageing portfoli 

  Summary

  Introduced with the Medical Indemnity Legislation Amendment (Competitive Neutrality) Bill 2005, the bill imposes a competitive adjustment payment to be made by insurers that provide medical indemnity to members of medical defence organisations participating in the incurred but not reported indemnity scheme. 

  Bill | Explanatory Memorandum

• Industrial Chemicals (Notification and Assessment) Amendment Bill 2003

  Track (What's this?)

  Date

  28 May 2003 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health and Ageing portfolio 

  Summary

  Amends the

  Industrial Chemicals (Notification and Assessment) Act 1989

  to: increase the maximum quantity of new industrial chemicals that a manufacturer or importer can introduce under the Commercial Evaluation Permit system from 2 000 to 4 000 kilograms; align the renewal deadline for the registration of introducers of industrial chemicals with the expiry date of registration (i.e. 31 August); require notification of non-renewal by 31 August; abolish the urgent handling fee and establish late renewal penalties for renewals received after the renewal deadline; and remove fees and charges provisions from the Act so that they may be specified in regulations. Also contains application and saving provisions. 

  Bill | Explanatory Memorandum

• Health Insurance Commission Amendment Bill 2002

  Track (What's this?)

  Date

  21 Mar 2002 

  Chamber

  Senate 

  Status

  Act 

  Portfolio

  Health and Ageing portfolio 

  Bill | Explanatory Memorandum

• Health Care (Appropriation) Bill 1998

  Track (What's this?)

  Date

  28 May 1998 

  Chamber

  House of Representatives 

  Status

  Act 

  Portfolio

  Health and Family Services portfolio 

  Bill

• Australia New Zealand Food Authority Amendment Bill (No. 2) 1997

  Track (What's this?)

  Date

  28 May 1997 

  Chamber

  Senate 

  Status

  Act 

  Portfolio

  Health and Family Services portfolio 

  Bill | Explanatory Memorandum

• Therapeutic Goods Amendment Bill 1997

  Track (What's this?)

  Date

  26 Mar 1997 

  Chamber

  Senate 

  Status

  Act 

  Portfolio

  Health and Family Services portfolio 

  Bill